Trasylol

Active Ingredient(s): Aprotinin
FDA Approved: * December 29, 1993
Pharm Company: * BAYER PHARMS
Category: Blood Clotting (Hemostasis)

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Trasylol Overview

The drug aprotinin (Trasylol, previously Bayer and now Nordic Group pharmaceuticals), is a small protein bovine pancreatic trypsin inhibitor (BPTI), or basic trypsin inhibitor of bovine pancreas, which is an antifibrinolytic molecule that inhibits trypsin and related proteolytic enzymes. Under the trade name Trasylol, aprotinin was used as a medication administered by injection to reduce bleeding during complex surgery, such as heart and liver surgery. Its main effect is the slowing down of ...

Read more Trasylol Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Aprotinin

Recent Trasylol Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Aprotinin
  • Injection: 10,000kiu/ml, 1000000kiu/ml, 10000kiu/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Aprotinin or a similar ingredient: (1 result)